President Joe Biden won an estimated 57 percent of union households across America in last year's election, but one of his earliest actions in the White House on Wednesday a flurry of criticism from leading labor groups: his executive order revoking federal permitting for the long-delayed Keystone XL pipeline project.

"Deeply disappointed," said the head of the North American Building Trades Unions, which endorsed Mr. Biden in October. "Will kill thousands of good-paying #UNION jobs!" tweeted the Laborers' International Union of North America. "Sadly, the Biden Administration has now put thousands of union workers out of work," lamented the United Association of Union Plumbers and Pipefitters.
https://komonews.com/news/nation-world/labor-unions-criticize-biden-action-against-keystone-xl-pipeline

Big pharma is smiling big right now. The big three insulin producers are Eli Lilly and Company, Novo Nordisk A/S, and Sanofi S.A., in which they dominate more than 90% of the world insulin market by value. After swearing-in, U.S. President Joe Biden’s HHS froze the Trump administration’s December 2020 drug policy that mandates community health centers to pass on all their insulin and epinephrine discount savings to patients.

The rule was finalized in late December 2020. The drug rule was put in place to benefit patients who have a hard time paying for expensive insulin and allergy medication. Former President Trump campaigned on lowering the price of important pharmaceutical drugs like insulin, which is used to treat diabetes, and epinephrine. Diabetes afflicts over a quarter of Medicare beneficiaries and drives billions in Medicare spending every year. More than 20 million Americans have diabetes, in which the body fails to properly use sugar from food due to insufficient insulin, a hormone produced in the pancreas.